Cite

HARVARD Citation

    Marshall, A. et al. (2018). Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe. Lancet gastroenterology and hepatology. pp. 125-133. [Online]. 
  
Back to record